|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Tarsus Pharmaceuticals, Inc. (TARS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
46,505,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tarsus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. Co.'s primary product candidate, TP-03, is an investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. Co. is developing product candidates to address targeted diseases with unmet medical needs, which include TP-03 for the potential treatment of Meibomian Gland Disease, TP-04 for the potential treatment of rosacea, and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
38,421 |
77,537 |
172,136 |
246,391 |
| Total Sell Value |
$3,117,468 |
$5,295,300 |
$9,647,902 |
$11,729,373 |
| Total People Sold |
4 |
4 |
8 |
8 |
| Total Sell Transactions |
5 |
8 |
29 |
36 |
| End Date |
2025-10-09 |
2025-07-08 |
2025-01-07 |
2024-01-08 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Whitfield Dianne C. |
Chief Human Resources Officer |
• – – |
2026-01-02 |
4 |
AS |
$80.09 |
$1,255,684 |
D/D |
(15,565) |
23,393 |
|
- |
|
| Azamian Bobak R. |
President/CEO and Board Chair |
• • – |
2025-12-24 |
4 |
AS |
$82.41 |
$495,089 |
I/I |
(6,000) |
857,991 |
|
- |
|
| Whitfield Dianne C. |
Chief Human Resources Officer |
• – – |
2025-12-16 |
4 |
AS |
$80.10 |
$592,500 |
D/D |
(7,397) |
38,958 |
|
- |
|
| Neervannan Seshadri |
Chief Operating Officer |
• – – |
2025-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
475 |
475 |
|
- |
|
| Neervannan Seshadri |
Chief Operating Officer |
• – – |
2025-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
950 |
79,183 |
|
- |
|
| Lin Elizabeth Yeu |
Chief Medical Officer |
• – – |
2025-12-16 |
4 |
S |
$79.50 |
$165,201 |
D/D |
(2,078) |
21,941 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2025-12-15 |
4 |
AS |
$80.71 |
$846,862 |
I/I |
(10,446) |
0 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2025-12-15 |
4 |
AS |
$80.80 |
$1,017,816 |
D/D |
(12,500) |
128,832 |
|
- |
|
| Lin Elizabeth Yeu |
Chief Medical Officer |
• – – |
2025-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,819 |
24,019 |
|
- |
|
| Azamian Bobak R. |
President/CEO and Board Chair |
• • – |
2025-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
51,885 |
1,750 |
|
- |
|
| Azamian Bobak R. |
President/CEO and Board Chair |
• • – |
2025-09-24 |
4 |
AS |
$55.37 |
$332,220 |
I/I |
(6,000) |
812,106 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2025-09-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
141,332 |
|
- |
|
| Morrison Scott W |
Director |
– • – |
2025-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,334 |
4,684 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2025-09-08 |
4 |
S |
$57.00 |
$1,545,612 |
D/D |
(27,116) |
143,332 |
|
- |
|
| Azamian Bobak R. |
President/CEO and Board Chair |
• • – |
2025-08-11 |
4 |
AS |
$50.00 |
$300,000 |
I/I |
(6,000) |
818,106 |
|
- |
|
| Farrow Jeffrey S |
See Remarks |
• – – |
2025-06-17 |
4 |
S |
$40.42 |
$550,035 |
D/D |
(13,608) |
36,704 |
|
- |
|
| Farrow Jeffrey S |
See Remarks |
• – – |
2025-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,881 |
50,312 |
|
- |
|
| Lin Elizabeth Yeu |
Chief Medical Officer |
• – – |
2025-06-16 |
4 |
S |
$41.08 |
$41,326 |
D/D |
(1,006) |
7,694 |
|
- |
|
| Lin Elizabeth Yeu |
Chief Medical Officer |
• – – |
2025-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,350 |
8,700 |
|
- |
|
| Yarno Wendy L |
Director |
– • – |
2025-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,350 |
13,700 |
|
- |
|
| Morrison Scott W |
Director |
– • – |
2025-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,350 |
3,350 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2025-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,350 |
170,448 |
|
- |
|
| Chaudhuri Bhaskar |
Director |
– • – |
2025-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,350 |
8,700 |
|
- |
|
| Goldberg Andrew D. |
Director |
– • – |
2025-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,350 |
16,700 |
|
- |
|
| Mottiwala Aziz |
Chief Commercial Officer |
• – – |
2025-06-09 |
4 |
AS |
$43.76 |
$765,800 |
D/D |
(17,500) |
47,557 |
|
- |
|
269 Records found
|
|
Page 1 of 11 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
